NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Health issues impacting patients with rare diseases. Telehealth. Step Therapy. H.R.2279/S.2546: Safe Step Act. Notice of Benefit Payment Parameters. Surprise Medical Billing. Pre-Existing Conditions. User Fee Negotiations. Physician Fee Schedule. Value Based Purchasing. Integrated Review Panel. Regulation and Guidance Reform. Affordable Care Act. COVID-19 Related Issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CORINNE ALBERTS | — |
| ROSE AVELLINO GALLAGHER | — |
| HEIDI ROSS | — |
| RICHARD WHITE New | — |
Medicare/Medicaid MMM
Medicare issues impacting patients with rare diseases. Medicaid issues impacting patients with rare diseases. Medicare Part D Program. Section 1115 Medicaid Waivers. Medicaid Drug Rebates. Medicaid Expansion. Value-Based Payments. Prior Authorization.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CORINNE ALBERTS | — |
| ROSE AVELLINO GALLAGHER | — |
| HEIDI ROSS | — |
Budget/Appropriations BUD
Public Health Agency Appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HEIDI ROSS | — |
Pharmacy PHA
Pharmaceutical issues impacting patients with rare diseases. Prescription Drug Pricing. NBPP Proposed Rule. Biosimilar User Fee Act (BsUFA). Prescription Drug User Fee Act (PDUFA).
| Lobbyist | Covered position, as disclosed |
|---|---|
| CORINNE ALBERTS | — |
| HEIDI ROSS | — |
| RICHARD WHITE New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.